Single-cell transcriptome profiling of tumour tissue isolates allows the characterization of
heterogeneous tumour cells along with neighbouring stromal and immune cells. Here we adopt …

Glioblastoma (GBM) is the most common and aggressive primary brain tumor. To better
understand how GBM evolves, we analyzed longitudinal genomic and transcriptomic data from …

Microsatellite instability (MSI) refers to the hypermutability of short repetitive sequences in
the genome caused by impaired DNA mismatch repair. Although MSI has been studied for …

Advanced metastatic cancer poses utmost clinical challenges and may present molecular
and cellular features distinct from an early-stage cancer. Herein, we present single-cell …

Recent advances in sequencing technologies have initiated an era of personal genome
sequences. To date, human genome sequences have been reported for individuals with …

Immunotherapy for metastatic colorectal cancer is effective only for mismatch repair-deficient
tumors with high microsatellite instability that demonstrate immune infiltration, suggesting …

The consensus molecular subtype (CMS) classification of colorectal cancer is based on
bulk transcriptomics. The underlying epithelial cell diversity remains unclear. We analyzed …

A number of recent reports have demonstrated that only CD133-positive cancer cells of
glioblastoma multiforme (GBM) have tumor-initiating potential. These findings raise an attractive …

Tumor recurrence following treatment is the major cause of mortality for glioblastoma multiforme
(GBM) patients. Thus, insights on the evolutionary process at recurrence are critical for …

A substantial fraction of disease-causing mutations are pathogenic through aberrant splicing.
Although genome profiling studies have identified somatic single-nucleotide variants (SNVs…